Tuesday 13 October 2026
Export PG’s income statement to Excel — free account
Procter & Gamble Company (The)
PG Consumer Defensive Household & Personal Products
Procter & Gamble Company (The)’s revenue for fiscal 2026 (year ended June 2026) was $87.0 billion, up 3.26% from fiscal 2025. In the quarter to June 2026, revenue grew 1.50%, EPS fell 15.2%, free cash flow grew 2.06% and total debt fell 1.07%, each against the same quarter a year earlier. Member of the S&P 500 and Dow Jones; dividend growth for ten consecutive years, revenue growth for five.
152.78
0.42
−0.27%
Follow PG
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to June
| Group | Line | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Trend | 2027e | 2028e | 2029e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | 83.24 | 70.73 | 89.08 | 94.34 | 121.54 | 122.18 | 135.83 | 146.28 | 138.14 | 137.62 |
Analyst estimates 2027–2029 Powerpack |
|||
| High | 94.67 | 96.90 | 126.60 | 146.92 | 164.98 | 165.35 | 158.38 | 180.43 | 179.99 | 167.25 | |||||
| People | |||||||||||||||
| People | Employees | 95,000 | 92,000 | 97,000 | 99,000 | 101,000 | 106,000 | 107,000 | 108,000 | 109,000 | 104,000 | ||||
| Revenue/emp, $m | 0.68 | 0.73 | 0.70 | 0.72 | 0.75 | 0.76 | 0.77 | 0.78 | 0.77 | 0.84 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | 65,058 | 66,832 | 67,684 | 70,950 | 76,118 | 80,187 | 82,006 | 84,039 | 84,284 | 87,032 | ||||
| Gross margin, % | 49.83 | 48.48 | 48.63 | 50.32 | 51.25 | 47.43 | 47.86 | 51.39 | 51.16 | 50.18 | |||||
| EBT | 13,257 | 13,326 | 6,069 | 15,834 | 17,615 | 17,995 | 18,353 | 18,761 | 20,167 | 20,377 | |||||
| EBT margin, % | 20.38 | 19.94 | 8.97 | 22.32 | 23.14 | 22.44 | 22.38 | 22.32 | 23.93 | 23.41 | |||||
| Net income | 15,411 | 9,861 | 3,966 | 13,103 | 14,352 | 14,793 | 14,738 | 14,974 | 16,065 | 16,144 | |||||
| Depreciation | 2,820 | 2,834 | 2,824 | 3,013 | 2,735 | 2,807 | 2,714 | 2,896 | 2,847 | 3,160 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | 25.04 | 26.42 | 27.03 | 28.53 | 30.87 | 33.27 | 34.63 | 35.61 | 35.86 | 37.29 | ||||
| Earnings | 5.80 | 3.75 | 1.45 | 5.13 | 5.69 | 6.00 | 6.07 | 6.18 | 6.67 | 6.75 | |||||
| Cash flow | 4.91 | 5.88 | 6.09 | 7.00 | 7.45 | 6.94 | 7.11 | 8.41 | 7.58 | 8.38 | |||||
| Capex | (1.08) | (1.36) | (1.18) | (1.22) | (1.11) | (1.26) | (1.27) | (1.26) | (1.56) | (1.67) | |||||
| Free cash flow | 3.83 | 4.51 | 4.91 | 5.77 | 6.34 | 5.67 | 5.84 | 7.15 | 6.02 | 6.71 | |||||
| Book value | 21.47 | 20.91 | 19.00 | 18.85 | 18.92 | 19.44 | 19.87 | 21.42 | 22.25 | 23.27 | |||||
| Shares, m | 2,598 | 2,529 | 2,504 | 2,487 | 2,466 | 2,410 | 2,368 | 2,360 | 2,350 | 2,334 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | 15.03 | 20.83 | 75.68 | 23.31 | 23.76 | 24.17 | 25.16 | 26.29 | 23.85 | 21.69 | ||||
| P/S | 3.48 | 2.96 | 4.09 | 4.19 | 4.37 | 4.32 | 4.38 | 4.57 | 4.44 | 3.93 | |||||
| P/B | 4.13 | 3.81 | 5.93 | 6.47 | 7.27 | 7.53 | 7.77 | 7.72 | 7.27 | 6.39 | |||||
| EV/Sales | 3.73 | 3.25 | 4.38 | 4.45 | 4.66 | 4.62 | 4.70 | 4.84 | 4.74 | 4.21 | |||||
| EV/FCF | 24.43 | 19.01 | 24.12 | 22.00 | 22.68 | 27.12 | 27.89 | 24.13 | 28.22 | 23.41 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | 12,753 | 14,867 | 15,242 | 17,403 | 18,371 | 16,723 | 16,848 | 19,846 | 17,817 | 19,556 | ||||
| Capex | (2,813) | (3,448) | (2,953) | (3,043) | (2,745) | (3,046) | (3,016) | (2,976) | (3,666) | (3,901) | |||||
| Free cash flow | 9,940 | 11,419 | 12,289 | 14,360 | 15,626 | 13,677 | 13,832 | 16,870 | 14,151 | 15,655 | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | (3,716) | (4,917) | (7,538) | (4,989) | (10,041) | (11,428) | (13,108) | (8,918) | (10,666) | (12,486) | ||||
| Total debt | 31,592 | 31,286 | 30,092 | 34,720 | 31,988 | 31,493 | 34,607 | 32,460 | 34,508 | 34,138 | |||||
| Net debt | 16,455 | 19,436 | 19,805 | 18,539 | 21,700 | 24,279 | 26,361 | 22,978 | 24,952 | 24,196 | |||||
| Shareholders’ equity | 55,778 | 52,883 | 47,579 | 46,878 | 46,654 | 46,854 | 47,065 | 50,559 | 52,284 | 54,311 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | 12.18 | 7.95 | 3.11 | 10.83 | 11.70 | 12.23 | 12.07 | 12.00 | 12.67 | 12.52 | ||||
| ROIC | 11.91 | 11.55 | 5.09 | 15.01 | 16.45 | 15.65 | 15.44 | 15.76 | 16.55 | 15.72 | |||||
| ROE | 26.99 | 17.78 | 7.37 | 27.56 | 30.59 | 31.51 | 31.15 | 30.40 | 30.97 | 29.99 | |||||
Negative figures in brackets.
Fiscal years to Jun 2026 · latest quarter Jun 2026
Charts ten years each
Procter & Gamble Company (The) vs peers in Household & Personal Products (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| PG Procter & Gamble Company (The) | $351.3B | 22.6× | 20.9× | +1.50% (above 0%: growing) | −15.23% (below 0%: shrinking) | +2.06% (above 0%: growing) | 48.50% | 18.62% | |
| UL Unilever PLC | $134.1B | 10.6× | — | +8.58% (above 0%: growing) | +8.84% (above 0%: growing) | −19.66% (below 0%: shrinking) | 0.00% | 0.00% | Compare |
| CL Colgate-Palmolive Company | $70.4B | 35.4× | 23.9× | +4.91% (above 0%: growing) | −5.43% (below 0%: shrinking) | +11.73% (above 0%: growing) | 61.48% | 18.95% | Compare |
| EL The Estee Lauder Companies Inc. | $35.5B | 196× | 28.0× | +6.33% (above 0%: growing) | n/m | +7.87% (above 0%: growing) | 75.46% | (1.08%) | Compare |
| KVUE Kenvue Inc. | $34.0B | 20.5× | 18.6× | +3.02% (above 0%: growing) | +9.09% (above 0%: growing) | +17.07% (above 0%: growing) | 58.18% | 17.67% | Compare |
| KMB Kimberly-Clark Corporation | $32.5B | 16.8× | 14.4× | +0.62% (above 0%: growing) | −32.03% (below 0%: shrinking) | −4.79% (below 0%: shrinking) | 38.27% | 15.11% | Compare |
| CHD Church & Dwight Co., Inc. | $23.3B | 32.0× | 26.3× | +1.57% (above 0%: growing) | +10.26% (above 0%: growing) | +23.33% (above 0%: growing) | 45.35% | 18.07% | Compare |
| CLX The Clorox Company | $10.1B | 17.5× | 14.8× | −2.01% (below 0%: shrinking) | −50.37% (below 0%: shrinking) | +11.42% (above 0%: growing) | 41.27% | 13.24% | Compare |
| ELF e.l.f. Beauty | $6.5B | 110× | 21.2× | +35.52% (above 0%: growing) | +91.53% (above 0%: growing) | +447.39% (above 0%: growing) | 83.20% | 21.37% | Compare |
| Median of peers | $33.2B | 26.3× | 21.2× | +3.97% | +8.84% | +11.57% | 51.76% | 16.39% |
PG metrics, ten years each
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
Procter & Gamble Company (The) (PG) key facts
- Strength: Procter & Gamble Company (The)’s revenue for fiscal 2026 (year ended June 2026) was $87.0 billion, up 3.26% from fiscal 2025.
- Procter & Gamble Company (The) (PG) is a Household & Personal Products company in the Consumer Defensive sector, listed on the New York Stock Exchange.
- As of October 12, 2026, PG traded at $153.02, a market capitalization of $355.8 billion.
- Procter & Gamble Company (The) pays an annual dividend of $4.29 per share, a yield of 2.80%, with a payout ratio of 64.8%.
- Return on equity was 30.0% and debt-to-equity 0.63.
- Its Piotroski F-score is 6 out of 9 and its Altman Z-score is 5.43 (safe zone) for fiscal 2026.
Financial Analysis (summary)
Updated
Procter & Gamble recorded revenue of $87.0 billion in FY2026 and net income of $16.1 billion in FY2026. Operating cash flow was $19.6 billion in FY2026, while free cash flow was $15.7 billion in FY2026.
In Q4 FY2026, revenue was $21.2 billion and diluted EPS was $1.26. Total debt was $34.1 billion in FY2026, net debt was $24.2 billion in FY2026, and shareholders’ equity was $54.3 billion in FY2026. Capital returned to shareholders was $15.3 billion in FY2026.